Healthcare Pharmaceutical Biotech

DataMeds Regains Compliance With NASDAQ Listing Standards

October 20, 2026 6:00 AM

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its super intelligence (artificial intelligence) platform EinsteinRx™ and smart contracts platform PharmacyChain™, today announced that it has received a notification letter (the "Compliance Notice") from the Listing Qualifications Staff of the Nasdaq Stock Market,...

Read more

Clinical Maestro Expands AI-Native Intelligence Platform With Launch of VISION Plus

October 20, 2026 4:35 AM

Clinical Maestro today announced the launch of VISION Plus, the second major release of its AI-native intelligence platform for pharmaceutical business operations, following the introduction of Source Plus in September 2026. Clinical Maestro Expands AI-Native Intelligence Platform With Launch of VISION Plus / Source: Clinical Maestro (EZ Newswire) Building on the platform's specialized AI architecture, proprietary pharmaceutical intelligence...

Read more

Water Linked Uses Bioz Badges to Connect Subsea Engineers with Published Research

October 20, 2026 4:00 AM

Bioz, Inc., a scientific research intelligence platform that uses citation data to show how products are used in published research, has been selected by Water Linked, a Norwegian developer of compact underwater sensor technology for navigation, positioning, imaging, and communication, to provide Bioz Badges on selected product pages. The integration will give engineers, researchers, and subsea professionals direct access to relevant scientific...

Read more

IRLAB's Preclinical Research Underpinning Linepemat Published in Peer-Reviewed Journal

October 20, 2026 1:20 AM

IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company focused on discovering and developing new treatments for Parkinson's disease, today announced that that the research behind the investigational drug linepemat (IRL757) has been published in the scientific journal Bioorganic & Medicinal Chemistry Letters. Linepemat is being developed as a potential first-in-class treatment for apathy associated with Parkinson's disease and other...

Read more

Sisel International Leaders Visit Juárez, Mexico to Witness SiselNUTRIFY'S Community Impact

October 19, 2026 6:30 PM

Sisel International leaders Milo Acosta, Vice President of Global Sales; Thomas Mower, Director of Global Operations; and Kaden Mower, Sales and Marketing Manager, traveled to Juárez, Mexico, on September 18, 2026, to observe the SiselNUTRIFY program firsthand and meet children, families and community representatives benefiting from the company's ongoing partnership with Fundación Gazpro. SiselNUTRIFY is a vitamin-and-mineral supplement...

Read more

Big Island Oral Surgery Strengthens Access to Full Mouth Dental Implants and Oral Surgery Care in Hilo

October 19, 2026 4:30 PM

Big Island Oral Surgery is strengthening its focus on advanced dental implant and oral surgery care in Hilo, giving patients across Hawaii's Big Island access to a broader range of treatment options for tooth loss, jawbone deterioration, wisdom teeth, and other surgical dental needs. Owned by board-certified oral surgeon Dr. Benjamin Rotwein, Big Island Oral Surgery provides specialized care for patients who need more than routine dental...

Read more

How an Olympic Runner Found Relief From Fecal Incontinence

October 19, 2026 12:40 PM

The patient featured in this story was compensated by Medtronic. As a former Australian Olympian and Commonwealth Games marathon silver medalist, Krishna Stanton knew endurance. She knew how to keep going when her legs were tired. She knew how to trust her body over long distances. Still, nothing in her athletic career prepared her for the quiet, daily worry of living with bowel control problems. For years, the condition affected nearly every...

Read more

Solstice Health COO Jessa Cisewski Named a 2027 Wisconsin Titan 100 Honoree

October 19, 2026 11:35 AM

Transforming healthcare takes more than innovative ideas. It takes leaders with the vision to challenge what's always been done, the determination to build something better, and the passion to make a lasting difference. Jessa Cisewski, Chief Operating Officer of Solstice Health, embodies that kind of leadership. Solstice Health is proud to announce that Cisewski has been named a 2027 Wisconsin Titan 100 honoree, recognizing her as one of the...

Read more

IPC Expands Advocacy Efforts

October 19, 2026 10:00 AM

Independent Pharmacy Cooperative (IPC) is expanding its Government Relations Department to strengthen advocacy efforts on behalf of independent pharmacies nationwide. As part of this growth, IPC has promoted John Covello to Vice President of Government Relations and welcomes Dylan McGarry and Henry Marquard to the team. The expansion comes as independent pharmacies face an increasingly complex legislative and regulatory environment, with...

Read more

Edward Witt Reflects on Decades of Providing Medical Care Behind the Scenes of Live Music

October 19, 2026 9:55 AM

Edward Witt spent much of his professional life in clinics and hospitals, but some of his most unusual medical work happened far from a traditional exam room. For years, the Huntsville physician served as a medical resource for entertainers passing through the city's major civic venue. The role placed him behind the scenes with touring artists, crews, and performers working under tight schedules and demanding conditions. Over time, Witt became...

Read more

Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days

October 19, 2026 9:30 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that, based on its current growth trajectory, it expects U.S. revenue of approximately $15 million for the fourth quarter of 2026, with gross profit of approximately $10.5 million. Subscriptions are expected to generate more than three-quarters of fourth quarter U.S. revenue, and momentum toward this...

Read more

DirectTrust and GLEIF Partner to Advance Verifiable Organizational Identity to U.S. Healthcare

October 19, 2026 9:00 AM

DirectTrust and the Global Legal Entity Identifier Foundation (GLEIF) today announced that they are working together to develop a new Qualification Agent model within the verifiable Legal Entity Identifier (vLEI) Ecosystem Governance Framework. The model is intended to enable organizations with established certification or accreditation capabilities to qualify vLEI Issuers (QVIs), supporting broader adoption of verifiable organizational identity...

Read more

CVS Caremark: Why Transparency Matters in Pharmacy Benefits

October 19, 2026 8:45 AM

Understanding what drives health care costs has become increasingly important across the health care system. Employers, patients, providers and policymakers are looking for clearer insights into spending, treatment options and strategies that can help make medications and care more affordable and accessible. Key findings from the CVS Caremark-Employee Benefit News study on PBM transparency Recent research conducted by CVS Caremark and Employee...

Read more

Hepion Pharmaceuticals Receives Positive FDA Response on GV104 in Gambling Disorder, a Condition With No Approved Medication

October 19, 2026 8:01 AM

Hepion Pharmaceuticals, Inc. (OTCQB:HEPA) ("Hepion" or the "Company"), a biotechnology company developing a portfolio of diagnostic and therapeutic candidates for serious liver, immune, and inflammatory diseases, today announced that its wholly-owned subsidiary Gravitas Life Sciences, LLC ("GLS"), a clinical-stage biotechnology company developing therapeutic candidates in immunology and inflammation, has received written responses from the U.S....

Read more

DEA Denies Federal Marijuana Manufacturing License: Are State Operators Next?

October 19, 2026 6:00 AM

A recent U.S. Drug Enforcement Administration (DEA) decision denying a federal bulk-manufacturer application for Colorado-based MedPharm Research highlights a growing divide between state-authorized cannabis operations and federal controlled-substance standards. Signed by DEA Administrator Terrance C. Cole, the decision evaluated MedPharm's affiliated companies and their participation in Colorado's state-regulated recreational market,...

Read more

BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate

October 19, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce two major development milestones for BNT23001, its proprietary sublingual Cladribine oral dissolvable film ("ODF") drug candidate for the treatment of relapsing forms of multiple sclerosis ("MS"). The Company has completed Good Manufacturing Practice ("GMP")...

Read more

Hemogenyx Pharmaceuticals PLC Announces Feasibility Study Agreement

October 19, 2026 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO), the clinical-stage biopharmaceutical group announces that it has entered into a Feasibility Study Agreement (the "Agreement") with Nitto Denko Corporation ("Nitto") (TSE:6988), the Japan-based manufacturer of high-performance materials. Under the Agreement, the parties will evaluate whether Nitto's cell-targeted lipid nanoparticle ("ctLNP") drug delivery technology can deliver Hemogenyx's messenger RNA...

Read more

State Licensed Marijuana Operators Will Face Long Delays for DEA Federal Registrations

October 17, 2026 1:50 PM

MMJ International Holdings, a pharmaceutical development company pursuing FDA regulated cannabinoid medicines for Huntington's disease and multiple sclerosis, today explained why it is challenging the federal government's April 2026 marijuana rescheduling order in the U.S. Court of Appeals for the District of Columbia Circuit. The explanation follows public remarks by former Drug Enforcement Administration official Matthew Strait, who said...

Read more

New Scientific Evidence Presented at ANESTHESIOLOGY 2026 Strengthens the Case for Senzime's TetraGraph and Quantitative Neuromuscular Monitoring

October 17, 2026 1:20 PM

Senzime (STO:SEZI) (OTCQX:SNZZF) Senzime AB (publ), a global leader in precision-based patient monitoring solutions, today announced new scientific data presented at ANESTHESIOLOGY® 2026, the annual meeting of the American Society of Anesthesiologists (ASA). The research highlights important clinical and economic aspects of quantitative neuromuscular monitoring, including the benefits of Senzime's proprietary TetraGraph® technology. The...

Read more

Science and Medicine Group (SMG) Names Jasen Holness Senior Vice President, Sales and Marketing to Accelerate Customer Growth

October 16, 2026 6:55 PM

Science and Medicine Group ( SMG ), a market research and digital marketing company serving the life science, diagnostics, analytical instruments, and medical imaging industries, today announced Jasen Holness as Senior Vice President, Sales and Marketing. Holness joined SMG on September 28 and oversees sales and marketing across the company's market research and insights brands and its digital media brands, reporting to Chief Executive Officer...

Read more